Spiracur, a developer of an ultraportable and disposable negative pressure wound therapy (NPWT) devices, has been awarded the prestigious American Podiatric Medical Association's (APMA) Seal of Approval for its SNaP Wound Care System.
Spiracur’s SNaP Wound Care System’s (Smart Negative Pressure) design eliminates the electric or battery powered pump traditionally used to deliver NPWT.
The SNaP System is completely silent and lightweight, weighing only 2.2 ounces.
Spiracur president and CEO Gary Restani said the SNaP System offers proven wound care treatment in a small and discreet device that easily fits under clothing, which enables patients to maintain their daily routine activities without exposing their wound care treatment.
Spiracur said the interim analysis supports the efficacy and safety of the company’s mechanically powered SNaP System and non-inferiority compared to the traditional electrically powered Vacuum-Assisted Closure (VAC) System.